ANLON HEALTHCARE LIMITED

26 Aug 2025 - 29 Aug 2025 Individual Category Main Board BSE NSE

Min Investment

₹14924

Price Band

₹86-₹91

Issue Size

133 lakhs
Equity Shares

Lot Size

164 (per lot)

IPO Dates
img

26 Aug 2025

Open Date

img

29 Aug 2025

Close Date

img

01 Sep 2025

Allotment Date

img

03 Sep 2025

Listing Date

Anlon Healthcare IPO open date is August 26, 2025, and the closing date is August 29, 2025. This new IPO is a book-built issue of 1,33,00,000 equity shares worth up to Rs 121 crores. The issue is entirely a fresh issue of 1.33 crore shares worth up to Rs 121.03 crore. Anlon Healthcare IPO price band is Rs 86 to Rs 91 per share. As of now, the Anlon Healthcare IPO GMP has not started yet. Live IPO Grey Market Premium details will be available online. Anlon Healthcare IPO allotment status is available on Monday, September 1, 2025. Anlon Healthcare IPO lot size is 164 shares. The minimum investment for retail investors for one lot is Rs 14,924. The registrar for the Anlon Healthcare IPO is Kfin Technologies Ltd. The Anlon Healthcare IPO listing date is September 3, 2025.

Know Before Investing

Strengths icon

  • Certified for quality (ISO 9001:2015 multiple GMP and global DMFs) assuring consistent standards.
  • Over 65 APIs and intermediates cater to diverse pharma personal care and veterinary applications.
  • In-house R&D and quality control maintain purity and compliance supporting global expansion.

Weaknesses icon

  • Heavy revenue reliance on a handful of clients (top 10 account for 77-78%).
  • Operations concentrated at a single manufacturing unit raising risk from disruptions.
  • Brand and export presence still limited in the competitive API market with only ~3% of sales from exports.

About Anlon Healthcare Limited

Anlon Healthcare Ltd., established in 2013 and headquartered in Rajkot, Gujarat, specializes in the research-driven manufacture of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). With ISO 9001:2015, GMP, and WHO-GMP certified facilities, the company is recognized for adhering to global quality benchmarks. Anlon Healthcare have an advanced R&D infrastructure, facilitating the development and production of APIs that meet the stringent requirements of international health authorities, including the FDA and cGMP standards. Company's varios product portfolio features pharmaceutical bulk drugs, intermediates, and nutraceutical compounds, supports both domestic and international pharmaceutical manufacturers. The company has established itself as an API partner of choice due to its strong product pipeline, custom manufacturing services, and emphasis on continuous quality control. With strong operations and a commitment to regulatory compliance, Anlon Healthcare continues to contribute to pharma innovation and supply chain from India.

Founded

2013

Managing Director

Punitkumar R. Rasadia

Parent Organization

-

IPO Objectives

Anlon Healthcare intends to utilise the net proceeds from its IPO primarily towards repayment and/ or pre-payment, in whole or in part, of certain outstanding borrowings availed by the company and general corporate purposes.

Company Promoters

Punitkumar R. rasadia

Meet Atulkumar Vachhani

Mamata punitkumar Rasadia

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account